{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:31:37Z","timestamp":1778164297769,"version":"3.51.4"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Glioblastomas (GBMs) are highly aggressive brain tumors that have developed resistance to currently available conventional therapies, including surgery, radiation, and systemic chemotherapy. In this study, we investigated the safety of a live attenuated Japanese encephalitis vaccine strain (JEV-LAV) virus as an oncolytic virus for intracerebral injection in mice. We infected different GBM cell lines with JEV-LAV to investigate whether it had growth inhibitory effects on GBM cell lines in vitro. We used two models for evaluating the effect of JEV-LAV on GBM growth in mice. We investigated the antitumor immune mechanism of JEV-LAV through flow cytometry and immunohistochemistry. We explored the possibility of combining JEV-LAV with PD-L1 blocking therapy. This work suggested that JEV-LAV had oncolytic activity against GBM tumor cells in vitro and inhibited their growth in vivo. Mechanistically, JEV-LAV increased CD8+ T cell infiltration into tumor tissues and remodeled the immunosuppressive GBM microenvironment that is non-conducive to immunotherapy. Consequently, the results of combining JEV-LAV with immune checkpoint inhibitors indicated that JEV-LAV therapy improved the response of aPD-L1 blockade therapy against GBM. The safety of intracerebrally injected JEV-LAV in animals further supported the clinical use of JEV-LAV for GBM treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2023.982180","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T04:36:45Z","timestamp":1681187805000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity"],"prefix":"10.3389","volume":"14","author":[{"given":"Zhongbing","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shichuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongheng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunmeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-016-1497-x","article-title":"Survival in glioblastoma: a review on the impact of treatment modalities","volume":"18","author":"Delgado-L\u00f3pez","year":"2016","journal-title":"Clin Trans Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of glioblastoma after chimeric antigen receptor T-cell therapy","volume":"375","author":"Brown","year":"2016","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov174","article-title":"Immunomodulation: checkpoint blockade etc","volume":"17","author":"Curry","year":"2015","journal-title":"Neuro Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-19-0261","article-title":"A randomized double-blind placebo-controlled phase II trial of dendritic cell vaccine ICT-107 in newly diagnosed patients with glioblastoma","volume":"25","author":"Wen","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716435","article-title":"Recurrent glioblastoma treated with recombinant poliovirus","volume":"379","author":"Desjardins","year":"2018","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02180","article-title":"Flavivirus receptors: Diversity, identity, and cell entry","volume":"9","author":"Laureti","year":"2018","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/mBio.01683-18","article-title":"Treatment of human glioblastoma with a live attenuated zika virus vaccine candidate","volume":"9","author":"Chen","year":"2018","journal-title":"mBio"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.144619","article-title":"Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade","volume":"6","author":"Nair","year":"2021","journal-title":"JCI Insight"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.105","article-title":"Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities","volume":"28","author":"Yu","year":"2010","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the united states in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of glioblastoma: State of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA: Cancer J Clin"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"Barker","year":"2008","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2020.1762568","article-title":"Glioblastoma multiforme: novel therapeutic targets","volume":"24","author":"Muir","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0316-z","article-title":"Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations","volume":"6","author":"Gong","year":"2018","journal-title":"J immunother Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with b-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory Large b-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/172603a0","article-title":"Actively acquired tolerance of foreign cells","volume":"172","author":"Billingham","year":"1953","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-014-0261-0","article-title":"Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye","volume":"29","author":"Medawar","year":"1948","journal-title":"Br J Exp Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-018-0057-5","article-title":"Microglial signatures and their role in health and disease","volume":"19","author":"Butovsky","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2022.102181","article-title":"Diversity and function of brain-associated macrophages","volume":"76","author":"Mildenberger","year":"2022","journal-title":"Curr Opin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/wco.0000000000000825","article-title":"Update on T cells in the virally infected brain: friends and foes","volume":"33","author":"Ai","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2022.10.005","article-title":"The CNS mononuclear phagocyte system in health and disease","volume":"110","author":"Mundt","year":"2022","journal-title":"Neuron"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24294","article-title":"The multitaskers of the brain: Glial responses to viral infections and associated post-infectious neurologic sequelae","volume":"71","author":"Dav\u00e9","year":"2023","journal-title":"Glia"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.36","article-title":"Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy","volume":"16","author":"Topalian","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq001","article-title":"Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo\/neg monocytes, tumor factors, and dexamethasone","volume":"12","author":"Gustafson","year":"2010","journal-title":"Neuro Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-20-3262","article-title":"Preclinical modeling of surgery and steroid therapy for glioblastoma reveals changes in immunophenotype that are associated with tumor growth and outcome","volume":"27","author":"Otvos","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/jci141614","article-title":"Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy","volume":"131","author":"Panagioti","year":"2021","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1200\/edbk_159084","article-title":"Current state of immune-based therapies for glioblastoma","volume":"35","author":"Lim","year":"2016","journal-title":"Am Soc Clin Oncol Educ book Am Soc Clin Oncol Annu Meeting"},{"key":"B31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4149\/av_2018_102","article-title":"Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system","volume":"62","author":"Al-Obaidi","year":"2018","journal-title":"Acta Virol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1042\/ebc20220082","article-title":"Astrocytes in the pathophysiology of neuroinfection","volume":"67","author":"Zorec","year":"2023","journal-title":"Essays Biochem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01050-22","article-title":"Lab-Attenuated rabies virus facilitates opening of the blood-brain barrier by inducing matrix metallopeptidase 8","volume":"96","author":"Fang","year":"2022","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ccell.2018.03.011","article-title":"Oncolytic viruses as antigen-agnostic cancer vaccines","volume":"33","author":"Russell","year":"2018","journal-title":"Cancer Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/PPO.0b013e31824671c9","article-title":"Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates","volume":"18","author":"Wollmann","year":"2012","journal-title":"Cancer J (Sudbury Mass)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0516-0","article-title":"Oncolytic virotherapy for the treatment of malignant glioma","volume":"14","author":"Foreman","year":"2017","journal-title":"Neurotherapeutics"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000000276","article-title":"Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety","volume":"33","author":"Feroldi","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29743","article-title":"A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the republic of Korea","volume":"10","author":"Kim","year":"2014","journal-title":"Hum Vaccines immunother"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.06.040","article-title":"Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus","volume":"36","author":"Liu","year":"2018","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004290","article-title":"A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij hairpin of the viral e glycoprotein determines neurovirulence in mice","volume":"10","author":"Yun","year":"2014","journal-title":"PloS Pathog"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410x(88)90103-x","article-title":"Japanese Encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use","volume":"6","author":"Eckels","year":"1988","journal-title":"Vaccine"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.75.2.934-942.2001","article-title":"Molecular basis for attenuation of neurovirulence of a yellow fever Virus\/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE)","volume":"75","author":"Arroyo","year":"2001","journal-title":"J Virol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.03.007","article-title":"The immune system in oncolytic immunovirotherapy: Gospel, schism and heresy","volume":"26","author":"Vile","year":"2018","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1038\/s41598-020-61736-2","article-title":"Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responses","volume":"10","author":"Alayo","year":"2020","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.01.019","article-title":"Pre-existing immunity to oncolytic virus potentiates its immunotherapeutic efficacy","volume":"26","author":"Ricca","year":"2018","journal-title":"Mol Ther"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/v14112327","article-title":"Pre-existing HSV-1 immunity enhances anticancer efficacy of a novel immune-stimulating oncolytic virus","volume":"14","author":"Ding","year":"2022","journal-title":"Viruses"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax0701","article-title":"Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage","volume":"369","author":"Fluckiger","year":"2020","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-20-0134","article-title":"Retargeted and stealth-modified oncolytic measles viruses for systemic cancer therapy in measles immune patients","volume":"19","author":"Bah","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-021-01346-2","article-title":"Delivery of cancer therapies by synthetic and bio-inspired nanovectors","volume":"20","author":"Briolay","year":"2021","journal-title":"Mol Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2014.08.010","article-title":"Encapsulation of adenovirus serotype 5 in anionic lecithin liposomes using a bead-based immunoprecipitation technique enhances transfection efficiency","volume":"35","author":"Mendez","year":"2014","journal-title":"Biomaterials"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122192","article-title":"Giving oncolytic viruses a free ride: Carrier cells for oncolytic virotherapy","volume":"13","author":"Reale","year":"2021","journal-title":"Pharmaceutics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/2162402x.2015.1022302","article-title":"Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy","volume":"4","author":"Qiao","year":"2015","journal-title":"OncoImmunology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29202","article-title":"Newcastle Disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death","volume":"136","author":"Koks","year":"2015","journal-title":"Int J Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-79","article-title":"Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68","volume":"11","author":"Ehrig","year":"2013","journal-title":"J Trans Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3182562d59","article-title":"Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors","volume":"35","author":"Agarwalla","year":"2012","journal-title":"J immunother (Hagerstown Md 1997)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-14-0514","article-title":"Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors","volume":"20","author":"Wainwright","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.12.025","article-title":"Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas","volume":"86","author":"Zeng","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-17-0468","article-title":"Oncolytic adenovirus and tumor-targeting immune modulatory therapy improve autologous cancer vaccination","volume":"77","author":"Jiang","year":"2017","journal-title":"Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam7577","article-title":"Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade","volume":"10","author":"Samson","year":"2018","journal-title":"Sci Trans Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.982180\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T04:36:49Z","timestamp":1681187809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.982180\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2023.982180"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.982180","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"article-number":"982180"}}